SPHINGOLIPID METABOLISM AS A TARGET FOR THE CHEMOTHERAPY ENHANCEMENT IN SORAFENIB AND CISPLATIN TREATMENT

SPHINGOLIPID METABOLISM AS A TARGET FOR THE CHEMOTHERAPY ENHANCEMENT IN SORAFENIB AND CISPLATIN TREATMENT

Milica Stefanovic,
01/01/2014